INS and type 1 diabetes mellitus: While it would be ideal to fix the problem of altered glucagon release in T1D due to low levels of insulin in the portal circulation with exogenous delivery, any treatment that can potentially make glucagon respond more appropriately all the time in individuals with type 1 diabetes would indeed be welcome.